Provided by Tiger Trade Technology Pte. Ltd.

YieldMax MRNA Option Income Strategy ETF

39.10
+0.24000.62%
Post-market: 38.75-0.3500-0.90%19:55 EDT
Volume:185.81K
Turnover:7.20M
Market Cap:211.33M
PE:- -
High:39.53
Open:39.11
Low:37.67
Close:38.86
52wk High:42.63
52wk Low:13.60
Shares:5.40M
Float Shares:5.40M
Volume Ratio:0.58
T/O Rate:3.44%
Dividend:17.77
Dividend Rate:45.44%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna Inc. Stock Advances 7.0%, Outperforms Peers

Dow Jones
·
Sep 25

Moderna Inc Stock (MRNA) Moved Up by 5.91% on Sep 24: What Investors Need To Know

TradingKey
·
Sep 25

Pharmaceutical Stocks Jump. Moderna, Eli Lilly up over 3%; Novavax, Pfizer up Around 2%; Merck, Novo Nordisk up over 1%

Tiger Newspress
·
Sep 24

Mesoblast Wins FDA Nod for New Potency Assay on Ryoncil Batches

TIPRANKS
·
Sep 24

Moderna CEO's Surprising Comment Gives Clues About Where Drugmaker is Going Next

Dow Jones
·
Sep 24

Kaisa Health Rebrands as Qinghai Biotech Pharmaceutical on Stock Exchange

Stock News
·
Sep 23

Moderna rises 4.6%

TIPRANKS
·
Sep 23

Early notable gainers among liquid option names on September 23rd

TIPRANKS
·
Sep 23

These 'Moonshot' Biotech Stocks Could Break Out, Morgan Stanley Says. What Must Go Right.

Dow Jones
·
Sep 23

Option Movers | Micron Jumps 5%, $22.6M Put Sale Signals Bullish Conviction; Moderna Rises 6%, $7.9M Double Put Sale Bets Against Breakdown

Option Movers
·
Sep 23

Cboe data suggests bullish flow in Moderna with shares up 5.72%

TIPRANKS
·
Sep 23

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Sep 23

Moderna up over 7%, on Track for Highest Close Since January 2023

Dow Jones
·
Sep 22

Analysts Have Conflicting Sentiments on These Healthcare Companies: Pyxis Oncology (PYXS), Moderna (MRNA) and Eli Lilly & Co (LLY)

TIPRANKS
·
Sep 22

Forge Nano and Nanexa to Develop Gmp-Compatible Ald Manufacturing Equipment

Reuters
·
Sep 22

Nanexa, Forge Nano Enter Joint Development Deal on GMP-Scale ALD Equipment for PharmaShell Injectables

Reuters
·
Sep 22

Moderna Surges 12% to a New 52-Week High as Phase 3 Cancer Vaccine Data Set for October Release

Bellwether Stocks Movement
·
Sep 22

Moderna Inc. Stock Climbs 12.3%, Outperforms Peers

Dow Jones
·
Sep 22

Moderna Provides Details on Data Presentations at Upcoming Conferences

MT Newswires Live
·
Sep 22

Why Is Moderna Stock (MRNA) Soaring Today, September 21?

TIPRANKS
·
Sep 22